Three-in-One Stop Computed Topography Angiography(CTA) and CT Perfusion(CTP) in Cerebrovascular Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorXin Lou
About this trial
This research takes patients with cerebrovascular diseases as the research subjects and employs the experimental design of a prospective cohort study, aiming to innovatively develop and validate a "one-stop" multimodal CT examination scheme. The 301-CTAP multimodal CT technique implies that three modalities are acquired through a single collection, including head and neck CTA (head and neck CTA), multiphase CTA imaging of the brain (multiphase CTA), and CT perfusion imaging of the brain (CT perfusion).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age≥18 <100years
Head and neck artery stenosis/occlusion, moyamoya disease, aneurysm, artery dissection, etc., may include patients with acute stroke, chronic cerebral ischemia, and asymptomatic patients. After clinical assessment, CT perfusion imaging is required
The image quality meets the requirements of diagnosis and post-processing
Patients who follow the scanning strategy to complete the examination
Disqualifiers
< 18 years old
People who are allergic to iodine contrast agents, or who cannot be tested temporarily due to taking metformin or aminoglycoside drugs
Renal failure patient
Severe cardiac insufficiency
Trial population
Patients with cerebrovascular disease
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Three-in-One Stop Computed Topography Angiography and Perfusion（301-CTAP） in the diagnosis of cerebrovascular disease performance description
Three-in-One Stop computed topography angiography and computed topography perfusion in cerebrovascular disease performance, including lesions in the detection and imaging in the diagnosis of image quality, accuracy, sensitivity and specificity.
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Xin Lou
Lead sponsor
Chinese PLA General Hospital
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: